Does OBINUTUZUMAB Cause Hypertensive cardiomyopathy? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hypertensive cardiomyopathy have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.1% of all adverse event reports for OBINUTUZUMAB.
15
Reports of Hypertensive cardiomyopathy with OBINUTUZUMAB
0.1%
of all OBINUTUZUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Hypertensive cardiomyopathy From OBINUTUZUMAB?
Of the 15 reports, 15 (100.0%) required hospitalization.
Is Hypertensive cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Hypertensive cardiomyopathy?
METHOTREXATE (20)
CYCLOSPORINE (19)
TOCILIZUMAB (18)
TOFACITINIB (18)
ANAKINRA (17)
CANAKINUMAB (17)
OMEPRAZOLE (16)
BENDAMUSTINE (15)
ESCITALOPRAM OXALATE (15)
ROSIGLITAZONE (15)
Which OBINUTUZUMAB Alternatives Have Lower Hypertensive cardiomyopathy Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE